READ OUR NEW PRESS RELEASE!!  Our breakthrough technology enters the liquid biopsy field
HER2DX TALKS LOGO

Now on-demand

REGISTER HERE

Redefining precision oncology

Unlocking the full potential of patient information

We want to change how biomarkers are routinely used in oncology

Separator

Analyze
the Past

Analyzing
complex genomic
and clinical data

Separator

Decode
the present

Decoding biomarkers before,
during or after therapies
using different biopsy-based approaches

Separator

Reveal
the future

Revealing innovative tests of
high analytical complexity,
but easy-to-interpret results